Article Versions Notes

Li Y-R, Liu C-H, Sun W-C, Fan P-Y, Liu F-H, Chen T-H, Wu VC-C, Lin C, Hsiao C-C. The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone. Journal of Personalized Medicine. 2021; 11(9):828. https://doi.org/10.3390/jpm11090828

Li, Yan-Rong, Chi-Hung Liu, Wei-Chiao Sun, Pei-Yi Fan, Feng-Hsuan Liu, Tien-Hsing Chen, Victor Chien-Chia Wu, Chihung Lin, and Ching-Chung Hsiao. 2021. "The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone" Journal of Personalized Medicine 11, no. 9: 828. https://doi.org/10.3390/jpm11090828

Li, Y. -R., Liu, C. -H., Sun, W. -C., Fan, P. -Y., Liu, F. -H., Chen, T. -H., Wu, V. C. -C., Lin, C., & Hsiao, C. -C. (2021). The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone. Journal of Personalized Medicine, 11(9), 828. https://doi.org/10.3390/jpm11090828